These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38365684)

  • 21. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.
    Deng H; Wei Z; Du J; Shen Z; Zhou C
    Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses.
    Huang ZD; Liu ZZ; Liu YY; Fu YC; Lin LL; Hu C; Gu HY; Wei RX
    Front Immunol; 2021; 12():791621. PubMed ID: 35003112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
    Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
    Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G
    Front Immunol; 2023; 14():1091218. PubMed ID: 36969232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma.
    Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X
    Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
    Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
    Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
    Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
    J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma.
    You P; Liu S; Li Q; Xie D; Yao L; Guo C; Guo Z; Wang T; Qiu H; Guo Y; Li J; Zhou H
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15623-15640. PubMed ID: 37656244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach.
    Deng L; Mi J; Ruan X; Zhang G; Pan Y; Wang R
    Mediators Inflamm; 2022; 2022():4007469. PubMed ID: 36299414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories.
    Yin J; Zheng S; He X; Huang Y; Hu L; Qin F; Zhong L; Li S; Hu W; Zhu J
    Sci Rep; 2022 Nov; 12(1):20404. PubMed ID: 36437265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mononuclear phagocyte system-related multi-omics features yield head and neck squamous cell carcinoma subtypes with distinct overall survival, drug, and immunotherapy responses.
    Zhang C; Deng J; Li K; Lai G; Liu H; Zhang Y; Xie B; Zhong X
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):37. PubMed ID: 38279056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.